SCHEMBL5335050

SCHEMBL5335050

CCCOC(=O)C1=C(C)NC2=C(C(=O)C(C(=O)OC)C(C)C2)C1c1ccc(N(C)C)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 14/20 1.00
KDM4E B2RXH2 12/20 1.00
CASP1 P29466 8/20 1.00
GAA P10253 6/20 1.00
MAPT P10636 5/20 0.85
CASP7 P55210 3/20 0.85
HTT P42858 1/20 0.85
USP2 O75604 4/20 0.76
SMN1; SMN2 Q16637 4/20 0.76
MAPK1 P28482 2/20 0.76
HPGD P15428 2/20 0.76
ALOX15 P16050 2/20 0.73
NPSR1 Q6W5P4 1/20 0.73
L3MBTL1 Q9Y468 1/20 0.73
TP53 P04637 2/20 0.72
TSHR P16473 3/20 0.56
HSD17B10 Q99714 3/20 0.55
RECQL P46063 1/20 0.54
PKM P14618 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5333581 0.94 ALDH1A1 (0.88) ALDH1A1KDM4ECASP1GAAMAPT
SCHEMBL5334382 0.89 ALDH1A1 (0.81) ALDH1A1KDM4ECASP1GAAMAPT
SCHEMBL5482759 0.89 ALDH1A1 (0.81) ALDH1A1KDM4ECASP1GAAMAPT
SCHEMBL5336757 0.89 ALDH1A1 (0.81) ALDH1A1KDM4ECASP1GAAMAPT
SCHEMBL5332462 0.86 ALDH1A1 (0.84) ALDH1A1KDM4ECASP1GAAMAPT
SCHEMBL5309937 0.85 ALDH1A1 (0.74) ALDH1A1KDM4ECASP1GAAMAPT
SCHEMBL5331385 0.84 ALDH1A1 (0.73) ALDH1A1KDM4ECASP1GAAMAPT
SCHEMBL5334324 0.84 GAA (0.75) ALDH1A1KDM4ECASP1GAAMAPT
SCHEMBL5475309 0.84 GAA (0.89) ALDH1A1KDM4ECASP1GAAMAPT
SCHEMBL5474846 0.83 GAA (0.77) ALDH1A1KDM4ECASP1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070112015-A1 Substituted dihydropyridines and methods of use CHEMOCENTRYX, INC. (US) 2007-05-17 US disclosed
WO-2007051062-A2 SUBSTITUTED DIHYDROPYRIDINES AND METHODS OF USE CHEMOCENTRYX, INC. (US) 2007-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112015-A1 Substituted dihydropyridines and methods of use C3AR1, C5AR1, C5AR2 ALDH1A1 1488/4885KDM4E 4033/4885CASP1 951/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.